https://www.selleckchem.com/pr....oducts/act001-dmamcl
These results suggest that our generated liver organoids from different stages of NASH diseased mice might become a useful tool for in vitro studies of the molecular mechanism of NASH development and also for identifying novel biomarkers for early diagnosis of NASH disease. Glioblastoma (GBM) is one of the malignant tumors with high mortality, and the presence of the blood brain barrier (BB severely limits the penetration and tissue accumulation of therapeutic agents in the lesion of GBM. Active targeting nanotechnologies can ac
Like
Comment
Share
